The global pharmaceutical market exceeds $1.4 trillion, with drug discovery and market research requiring access to clinical trials, drug databases, and healthcare publications. Mobile proxies enable reliable access to healthcare data sources without triggering rate limits or geo-restrictions.
450K+ studies. Primary NIH registry. Rate limited for bulk access.
EMA trials database. Geo-restricted features.
International trial registry portal. Aggregates 17 registries.
BMC-operated. International standards.
Approved drugs, labels, and safety data.
Comprehensive drug data. Commercial API access limited.
115M+ compounds. NIH chemical database.
European medicines database. EU IP access preferred.
Track competitor drug development pipelines by monitoring clinical trial registrations, phase progressions, and regulatory submissions across global databases.
Monitor FDA, EMA, and other regulatory bodies for drug approvals, safety alerts, label changes, and guidance documents.
Collect and analyze medical publications from PubMed, medical journals, and conference proceedings for systematic reviews and meta-analyses.
Research healthcare providers, hospital networks, insurance plans, and medical device markets for commercial intelligence.
Healthcare data collection involves regulatory considerations. Our proxies support compliant research workflows:
Get reliable access to clinical trials, drug databases, and medical research.